Sylvie Bouchard

Directrice du médicament / Director of Medication


Sylvie Bouchard graduated in pharmacy at Laval University in Quebec. She also holds a diploma and a master’s degree in hospital pharmacy as well as an MBA in business management, obtained at the same university. In 2017, the Ordre des pharmaciens du Québec awarded her the Louis-Hébert Prize, the highest distinction for the recognition of excellence in her professional achievements, throughout her career.

Ms. Bouchard worked as a pharmacist in the health care facility and as a hospital pharmacy manager, first at the hospital affiliated university center of Quebec (CHAUQ) and the Hôtel-Dieu de Québec Center hospitalier universitaire de Québec ( CHUQ). She has worked in several clinical areas, with a marked interest in intensive care practice. In addition, it implemented robotization and drug distribution technologies at CHAUQ in 2001.

She joined the Medicines Council in April 2010, which became the National Institute of Excellence in Health and Social Services (INESSS) in 2011, and assumed several managerial roles. Ms. Bouchard held the position of Director drug as of April 2016. She is now director of drug evaluation and technology for purposes of reimbursement.

All Sessions by Sylvie Bouchard

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

Agenda: Day 2 Oct 6, 2020

12:00 pm

12:00 pm

Presentation: QUEBEC UPDATE

Prepare for the Potential National Implications of Québec’s New PLA System

In early summer 2021, INESSS announced a change in their guidelines for listing applications. Investigate how these revisions could potentially be picked up throughout the rest of the country, and arm your team with the knowledge to prepare for potential changes by:

  • Reviewing the learnings to-date in the Québec market

Understanding why INESSS / Québec

  • were driven to institute these particular changes
  • Gaining valuable insight into specifics you may have missed

Position your company to succeed in an uncertain environment with a solid public PLA strategy